Suppr超能文献

哌啶和哌嗪基森田-贝利斯-希尔曼加合物(MBHAs)的合成、抗脲酶活性、分子对接研究及ADMET预测

Synthesis, anti-urease, molecular docking study and ADMET predictions of piperidine and piperazine Morita-Baylis-Hillman Adducts (MBHAs).

作者信息

Aslam Samina, Ullah Sami, Ullah Hamid, Rehman Attiq Ur, Khan Naqeebullah, Baqi Abdul, Khan Yousaf

机构信息

Depatment of Chemistry, 66954 University of Balochistan , Quetta, Pakistan.

Department of Chemistry, Sardar Bahadur Khan Women University, Quetta Balochistan, Pakistan.

出版信息

Z Naturforsch C J Biosci. 2024 Nov 20. doi: 10.1515/znc-2024-0175.

Abstract

The current work describes an efficient synthesis of Morita-Baylis-Hillman adducts (MBHAs) derived heterocycles (, , , , , , , , and ) with the Michael addition of piperidine and piperazine heterocycles. The comparative studies of mono and di-hydrogen bond acceptors heterocycles, meta and para substituted nitro-phenyl rings and the isolated single diastereomer through molecular docking coupled with bioactivities displayed very important results. The biological significances were observed against urease enzyme (IC = 3.95 ± 0.10 µM). Almost all the compounds displayed different ranges of inhibition potential whereas the di-hydrogen bond donor diastereomers and were found to be highly potent against the targeted enzyme while the remaining had shown comparable inhibitory activity. The diastereomers and were the most active having minimum inhibitory concentration (MIC) IC = 3.95 ± 0.10 µM. All the synthesized compounds were docked and their best poses were explored for enhanced biological properties. The molecular docking studies revealed better binding interactions of the ligand with the target enzyme. Furthermore, ADMET predictions were also observed which revealed drug like properties for all the novel MBHAs based piperidine and piperazine derivatives.

摘要

当前的工作描述了一种通过哌啶和哌嗪杂环的迈克尔加成反应高效合成衍生自莫里塔-贝利斯-希尔曼加合物(MBHAs)的杂环化合物(、、、、、、、和)的方法。通过分子对接结合生物活性对单氢键受体和双氢键受体杂环、间位和对位取代的硝基苯环以及分离出的单一非对映异构体进行的比较研究显示了非常重要的结果。观察到这些化合物对脲酶具有生物学意义(IC = 3.95 ± 0.10 μM)。几乎所有化合物都表现出不同程度的抑制潜力,而双氢键供体非对映异构体和被发现对目标酶具有高效力,其余化合物表现出相当的抑制活性。非对映异构体和活性最高,最低抑制浓度(MIC)IC = 3.95 ± 0.10 μM。对所有合成化合物进行了对接,并探索了它们的最佳构象以增强生物学特性。分子对接研究揭示了配体与目标酶之间更好的结合相互作用。此外,还进行了ADMET预测,结果显示所有基于新型MBHAs的哌啶和哌嗪衍生物都具有类药物性质。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验